Xylem, Inc.

$19.00

SKU: XYL Category:

Description

Xylem, Inc.: How Its Recent Operational Excellence & Synergy Capture From Evoqua Integration Driving our Optimism! 

 

Xylem’s Third Quarter 2024 Earnings presented a mixed financial picture marked by strong profit margins and operational discipline but moderated revenue growth. CEO Matthew Pine highlighted robust earnings and record EBITDA margins achieved during the quarter due to disciplined execution across the business and efficient integration of Evoqua, which is now ahead of schedule in cost synergies.

Our Report Structure:

⦁ Company Overview
⦁ Investment Thesis
⦁ Key Drivers
⦁ Historical Quarterly Statement Analysis – Income Statement & Cash Flows
⦁ Historical Quarterly Balance Sheet Analysis
⦁ Historical Annual Financial Statement Analysis
⦁ Analysis Of Key Financial Ratios
⦁ Financial Forecasts For 3 Years
⦁ Forecasting The Capital Structure & Net Debt
⦁ Discounted Cash Flow Valuation
⦁ Trading Multiples
⦁ Key Risks
⦁ Disclosures

Want unlimited access to our reports? Purchase our $99 annual subscription!